Syndrome of inappropriate antidiuretic hormone secretion (SIADH)

Last updated: June 10, 2025

Syndrome of inappropriate antidiuretic hormone secretion (SIADH)

Watch later

Watch later

Somatostatin
Synthesis of adrenocortical hormones
Cortisol
Testosterone
Estrogen and progesterone
Phosphate, calcium and magnesium homeostasis
Parathyroid hormone
Vitamin D
Calcitonin
Congenital adrenal hyperplasia
Primary adrenal insufficiency
Waterhouse-Friderichsen syndrome
Hyperaldosteronism
Adrenal cortical carcinoma
Cushing syndrome
Conn syndrome
Thyroglossal duct cyst
Hyperthyroidism
Graves disease
Thyroid eye disease (NORD)
Toxic multinodular goiter
Thyroid storm
Hypothyroidism
Euthyroid sick syndrome
Hashimoto thyroiditis
Subacute granulomatous thyroiditis
Riedel thyroiditis
Thyroid cancer
Hyperparathyroidism
Hypoparathyroidism
Hypercalcemia
Hypocalcemia
Diabetes mellitus
Diabetic retinopathy
Diabetic nephropathy
Hyperpituitarism
Pituitary adenoma
Hyperprolactinemia
Prolactinoma
Gigantism
Acromegaly
Hypopituitarism
Pituitary apoplexy
Sheehan syndrome
Hypoprolactinemia
Constitutional growth delay
Diabetes insipidus
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Precocious puberty
Delayed puberty
Premature ovarian failure
Polycystic ovary syndrome
Androgen insensitivity syndrome
Kallmann syndrome
5-alpha-reductase deficiency
Autoimmune polyglandular syndrome type 1 (NORD)
Multiple endocrine neoplasia
Pancreatic neuroendocrine neoplasms
Zollinger-Ellison syndrome
Pheochromocytoma
Neuroblastoma
Opsoclonus myoclonus syndrome (NORD)
Adrenal insufficiency: Pathology review
Adrenal masses: Pathology review
Hyperthyroidism: Pathology review
Hypothyroidism: Pathology review
Thyroid nodules and thyroid cancer: Pathology review
Parathyroid disorders and calcium imbalance: Pathology review
Diabetes mellitus: Pathology review
Cushing syndrome and Cushing disease: Pathology review
Pituitary tumors: Pathology review
Hypopituitarism: Pathology review
Diabetes insipidus and SIADH: Pathology review
Multiple endocrine neoplasia: Pathology review
Hyperthyroidism medications
Hypothyroidism medications
Insulins
Hypoglycemics: Insulin secretagogues
Miscellaneous hypoglycemics
Adrenal hormone synthesis inhibitors
Mineralocorticoids and mineralocorticoid antagonists
Bones of the cranium
Anatomy of the cranial base
Anatomy of the orbit
Anatomy of the eye
Bones of the neck
Superficial structures of the neck: Cervical plexus
Superficial structures of the neck: Anterior triangle
Deep structures of the neck: Prevertebral muscles
Anatomy of the thyroid and parathyroid glands
Anatomy of the larynx and trachea
Anatomy of the pharynx and esophagus
Introduction to the cranial nerves
Anatomy of the olfactory (CN I) and optic (CN II) nerves
Anatomy of the oculomotor (CN III), trochlear (CN IV) and abducens (CN VI) nerves
Nasal cavity and larynx histology
Anatomy and physiology of the eye
Photoreception
Optic pathways and visual fields
Anatomy and physiology of the ear
Auditory transduction and pathways
Vestibular transduction
Vestibulo-ocular reflex and nystagmus
Olfactory transduction and pathways
Taste and the tongue
Glaucoma
Retinoblastoma
Laryngomalacia
Laryngitis
Bacterial epiglottitis
Eye conditions: Refractive errors, lens disorders and glaucoma: Pathology review
Eye conditions: Retinal disorders: Pathology review
Eye conditions: Inflammation, infections and trauma: Pathology review
Vertigo: Pathology review
Nasal, oral and pharyngeal diseases: Pathology review
Antihistamines for allergies
Acid reducing medications
Blood histology
Sepsis
Anaphylaxis
Food allergy
Blood products and transfusion: Clinical
Bites and stings: Clinical
Hematopoietic medications
Thrombolytics
Hemophilia
The nurse and doctor and the avoidable lawsuit (Coverys)
Traumatic brain injury: Pathology review
Concussion and traumatic brain injury
Traumatic brain injury: Clinical
Brain herniation
Drug administration and dosing regimens
Sympathomimetics: Direct agonists
Muscarinic antagonists
Cholinomimetics: Direct agonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
ACE inhibitors, ARBs and direct renin inhibitors
Thiazide and thiazide-like diuretics
Calcium channel blockers
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Laxatives and cathartics
Antidiarrheals
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Antiplatelet medications
Glucocorticoids
Opioid agonists, mixed agonist-antagonists and partial agonists
Nonbenzodiazepine anticonvulsants
Migraine medications
General anesthetics
Local anesthetics
Neuromuscular blockers
Opioid antagonists
Osmotic diuretics
Carbonic anhydrase inhibitors
Loop diuretics
Potassium sparing diuretics
PDE5 inhibitors
Estrogens and antiestrogens
Progestins and antiprogestins
Androgens and antiandrogens
Aromatase inhibitors
Uterine stimulants and relaxants
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines

Flashcards

Syndrome of inappropriate antidiuretic hormone secretion (SIADH)

0 of 12 complete

Questions

USMLE® Step 1 style questions USMLE

0 of 3 complete

Start
A 65-year-old man is brought to the emergency department because of nausea, vomiting, muscle weakness, and confusion. The symptoms began two days ago. Review of his medical record reveals that he has a recent diagnosis of depression for which fluoxetine therapy was initiated four-weeks ago by his psychiatrist. Temperature is 37.2°C (99°F), pulse is 78/min, and respiratory rate is 15/min and blood pressure is 117/78 mmHg. On physical examination, the patient has difficulty standing due to generalized weakness. Laboratory studies are as follows:    

 Laboratory value  Result  Reference Range 
 Sodium  118 mEq/L  136-146 mEq/L 
 Blood Urea Nitrogen  15 mg/dL  7-18 mg/dL 
 Creatinine  0.8 mg/dL  0.6-1.2 mg/dL 
 Glucose  105 mg/dL  70-110 mg/dL 
 Serum Osmolarity   241 mOsm/kg  275-295 mOsm/kg 
 Urine Osmolality  405 mOsm/kg  50-1,400 mOsm/kg 
     
The patient is provided with an infusion of 3% saline. Which of the following is a potential complication when using this solution? 

Transcript

Watch video only

Content Reviewers

How does your body know when to retain fluids and when to get rid of them?

It’s not like you just think to yourself “I’ve had too much water, better get rid of some.” (If you do, and it works, call us).

Your body uses chemicals called hormones to send widespread messages, kind of like how the P.A. system at school tells everyone to ignore the smoke billowing out of the science wing.

The antidiuretic hormone, abbreviated as ADH, is the hormone that controls water retention in the body.

It also constricts blood vessels, and incidentally the vasoconstrictor drug called vasopressin is just ADH. Cool! But that’s not what we’re talking about right now.

Anyways, the more ADH floating around in your blood, the more fluid you retain.

The less ADH in your blood, the more fluid you excrete.

The nephrons in the kidneys are the structures that physically control how much water is excreted from your body.

Nephrons are mostly a series of tubes attached end-to-end that type fluids and wastes towards the bladder.

These tubes though also allow fluids and electrolytes to move through the tube walls and back into the blood if needed.

ADH affects the last two-thirds of these tubes, called the distal convoluted tubule and the collecting ducts.

These tubes focus almost exclusively on reabsorbing water back into the blood.

The wall of these tubes are unsurprisingly made up of cells, a common trait of living things, but these cells have proteins called aquaporins.

Aquaporins allow water to move quickly in and out of the cells.

The more ADH floating around in the blood, the more aquaporins are available to... ahem...facilitate water movement through the cell (yo, wata, come over here for a sec).

So when ADH is low, most of the water flows through the distal convoluted tubule and the collecting duct, giving us diluted urine.

When ADH is high, aquaporins grab much of the water passing through the these tubes and throws them back into the blood.

When I drink a glass of water and that water is absorbed into my blood, my plasma osmolality drops, which means I’m diluting my blood with the water.

That means there’s more fluid for all those blood cells to bounce around in (wooo parrttayy).

The part of my brain called the hypothalamus sees this drop in plasma osmolality and tells the pituitary gland to slow down the release of ADH (that’s enough!).

Low ADH leads to lots of diluted urine (urine with low osmolality), which brings our plasma osmolality back to normal. What a nifty feedback loop.

Now suppose ADH continues to be released even though my plasma osmolality has dropped (stop it! STOP IT! pituitary gland whistling).

We’re going to continue retaining water, and as we drink more and more water, we might expect our plasma osmolality to continue dropping. However this isn’t exactly the case.

As more water is retained, it dilutes the other solutes floating around in our blood, like sodium.

The extra fluid also takes up more space in our blood vessels.

This taking up more space issue triggers another mechanism in our body that causes the hormone aldosterone to stop being released.

Less aldosterone floating around in the blood causes the body to start dumping sodium from the blood into the urine.

Concentration gradients cause water to follow sodium, so we end up with the excess water being excreted in the urine with the sodium, normalizing the fluid volume in the blood.

So now our body is removing sodium from blood that already has a lower concentration of sodium. Uh oh!

This means the plasma sodium osmolarity is dropping significantly.

This whole fiasco we’ve just talked about is called syndrome of inappropriate antidiuretic hormone, often abbreviated as SIADH.

Key Takeaways

Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is characterized by excessive release of antidiuretic hormone from the posterior pituitary gland or another source. The increase in fluid retention often results in dilutional hyponatremia in which the plasma sodium levels are lowered. SIADH may present with euvolemic hyponatremia with continued urinary sodium excretion. Urine osmolality is usually higher than serum osmolality. Very low serum sodium levels can lead to cerebral edema or seizures. Other symptoms of SIADH include fatigue, confusion, muscle weakness, nausea, vomiting, lack of appetite, and weight loss. Treatment usually involves fluid restriction, salt tablets, IV hypertonic saline, diuretics, and drugs like conivaptan, tolvaptan, or demeclocycline.